5 Revealing Analyst Questions From Artivion’s Q2 Earnings Call
AORT Q2 Deep Dive: Product Momentum and Pipeline Expansion Support Positive Outlook
Artivion (NYSE:AORT) Delivers Strong Q2 CY2026 Numbers
Second Quarter & Recent Business Highlights:
Artivion (AORT) To Report Earnings Tomorrow: Here Is What To Expect
3 Healthcare Stocks with Questionable Fundamentals
3 Small-Cap Stocks We Keep Off Our Radar
ATLANTA , July 28, 2026 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate in two upcoming...
ATLANTA , July 23, 2026 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that second quarter 2026 financial...